Davide Ruggero

Davide Ruggero

University of California, San Francisco

H-index: 54

North America-United States

About Davide Ruggero

Davide Ruggero, With an exceptional h-index of 54 and a recent h-index of 43 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of translation control, cancer, ribosomes, RNA biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress

Evolutionarily divergent mTOR remodels translatome for tissue regeneration

Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates

Elongation factor 1-alpha inhibitors and uses thereof

N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

AR inhibition increases MHC class I expression and improves immune response in prostate cancer

RAPIDASH: A tag-free enrichment of ribosome-associated proteins reveals compositional dynamics in embryonic tissues and stimulated macrophages

Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

Davide Ruggero Information

University

Position

Professor (UCSF)

Citations(all)

24740

Citations(since 2020)

11885

Cited By

17496

hIndex(all)

54

hIndex(since 2020)

43

i10Index(all)

79

i10Index(since 2020)

70

Email

University Profile Page

University of California, San Francisco

Google Scholar

View Google Scholar Profile

Davide Ruggero Skills & Research Interests

translation control

cancer

ribosomes

RNA biology

Top articles of Davide Ruggero

Title

Journal

Author(s)

Publication Date

miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress

Molecular Cancer Research

Neekkan Dey

Costas Koumenis

Davide Ruggero

Serge Y Fuchs

J Alan Diehl

2024/2/14

Evolutionarily divergent mTOR remodels translatome for tissue regeneration

Nature

Olena Zhulyn

Hannah D Rosenblatt

Leila Shokat

Shizhong Dai

Duygu Kuzuoglu-Öztürk

...

2023/8/3

Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates

Elife

Adele Francis Xu

Rut Molinuevo

Elisa Fazzari

Harrison Tom

Zijian Zhang

...

2023/6/12

Elongation factor 1-alpha inhibitors and uses thereof

2023/5/4

N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

Cancer research

Duygu Kuzuoglu-Ozturk

Ozlem Aksoy

Christin Schmidt

Robin Lea

Jon D Larson

...

2023/1/4

AR inhibition increases MHC class I expression and improves immune response in prostate cancer

Lisa N Chesner

Julie N Graff

Fanny Polesso

Alexis Smith

Arian Lundberg

...

2023

RAPIDASH: A tag-free enrichment of ribosome-associated proteins reveals compositional dynamics in embryonic tissues and stimulated macrophages

bioRxiv

Teodorus Theo Susanto

Victoria Hung

Andrew G Levine

Craig H Kerr

Yongjin Yoo

...

2023/12/7

Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

Nature Communications

Irati Macaya

Marta Roman

Connor Welch

Rodrigo Entrialgo-Cadierno

Marina Salmon

...

2023/10/10

Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3

Nature chemistry

Hao-Yuan Wang

Haojun Yang

Mikael Holm

Harrison Tom

Keely Oltion

...

2022/12

A tRF nucleator for Nucleolin in cancer metastasis

Molecular Cell

Yichen Xu

Davide Ruggero

2022/7/21

Localization of a TORC1-eIF4F translation complex during CD8+ T cell activation drives divergent cell fate

Molecular cell

Swantje Liedmann

Xueyan Liu

Clifford S Guy

Jeremy Chase Crawford

Diego A Rodriguez

...

2022/7/7

Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress

2022/5/19

Protein synthesis control in cancer: selectivity and therapeutic targeting

Joanna R Kovalski

Duygu Kuzuoglu‐Ozturk

Davide Ruggero

2022/4/19

Regulation of eIF4E guides a unique translational program to control erythroid maturation

Science Advances

Craig M Forester

Juan A Oses-Prieto

Nancy J Phillips

Sohit Miglani

Xiaming Pang

...

2022/12/23

Examining Myc-dependent translation changes in cellular homeostasis and cancer

Joanna R Kovalski

Yichen Xu

Davide Ruggero

2021/5/22

A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies

Developmental cell

Gerald C Tiu

Craig H Kerr

Craig M Forester

Pallavi S Krishnarao

Hannah D Rosenblatt

...

2021/7/26

Ferronostics: a next gen theranostic strategy to identify diseases susceptible treatment with therapies targeting the labile iron pool.

Michael Evans

Ning Zhao

Yung-Hua Wang

Adam Renslo

Youngho Seo

...

2021/5/1

Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function

Iscience

Honyin Chiu

Roberta Buono

Leandra V Jackson

Lee-or Herzog

Sharmila Mallya

...

2021/7/23

The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity

Nature metabolism

Crystal S Conn

Haojun Yang

Harrison J Tom

Kenji Ikeda

Juan A Oses-Prieto

...

2021/2

Releasing the brake on protein synthesis in hematopoietic stem cells

Cell Stem Cell

Craig M Forester

Davide Ruggero

2021/7/1

See List of Professors in Davide Ruggero University(University of California, San Francisco)